EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and In Vitro Biological Assessment of Novel Benzimidazole and Hydrazone Derivatives Against Pancreatic Cancer and Melanoma Cells

Beyza Ecem Oz Bedir iD, Tuba Ozdemir Sanci iD, Emine Terzi iD, Elif Ercan iD, Nour El-Huda Daoud, Ulviye Acar Çevik iD

Chemical Biology & Drug Design · 2026-06 · 107 (6)

DOI: 10.1111/cbdd.70349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 26.06.2026. Verfasst von Beyza Ecem Oz Bedir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey. Hauptthemen laut MEDLINE: Benzimidazoles, Hydrazones, Antineoplastic Agents, Drug Design. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, novel Benzimidazole‐Hydrazone derivatives ( 5A–5J ) were synthesized and evaluated for their in vitro anticancer activities against Panc‐1, SK‐MEL‐30, HeLa, and BEAS‐2B cell lines. WST‐1 cytotoxicity assays revealed that compound 5A displayed notable potency in SK‐MEL‐30 cells (IC 50 = 23.25 ± 1.40 μM), whereas compound 5H exhibited significant cytotoxicity in Panc‐1 cells (IC 50 = 27.6 ± 1.1 μM), with minimal effects on BEAS‐2B cells (> 200 μM), suggesting a favorable in vitro safety profile under the tested conditions. Flow cytometric analyses demonstrated that 5A and 5H induced apoptosis and enhanced the apoptotic response when combined with Cisplatin, increasing apoptotic rates up to 80% in SK‐MEL‐30 and 90% in Panc‐1 cells, respectively. Cell cycle analysis revealed that compound 5A induced G1 arrest in SK‐MEL‐30 cells, while compound 5H caused G2/M arrest in Panc‐1 cells. Wound healing assays further confirmed the antimigratory potential of both compounds, alone and in combination with Cisplatin. In silico ADMET profiling provided preliminary insights into the pharmacokinetic properties of compounds 5A and 5H , indicating generally acceptable drug‐likeness parameters within the limitations of computational prediction. Molecular docking analyses suggested potential interactions with the caspase‐3 active site; however, these findings should be interpreted as supportive computational observations and do not provide direct evidence of a specific molecular mechanism underlying the observed apoptotic effects. These findings indicated that compounds 5A and 5H exhibited notable in vitro anticancer activity and may serve as potential candidates for further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzimidazolesHydrazonesAntineoplastic AgentsDrug DesignHumansMelanomaApoptosisCell Line, TumorPancreatic NeoplasmsMolecular Docking SimulationCisplatinCaspase 3HeLa Cells

Stichwörter der Autor:innen

benzimidazolehydrazonemelanomapancreatic cancer

Substanzen

BenzimidazolesHydrazonesAntineoplastic AgentsbenzimidazoleCisplatinCaspase 3

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Yenimahalle Training and Research Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Department of Histology and Embryology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
  • Department of Pharmaceutical Chemistry, Graduate School, Anadolu University, Eskişehir, Turkey.

ORCID-Profile: Beyza Ecem Oz Bedir, Tuba Ozdemir Sanci, Emine Terzi, Elif Ercan, Ulviye Acar Çevik

Zitieren

APA

Bedir, B. E. O., Sanci, T. O., Terzi, E., Ercan, E., Daoud, N. E., & Çevik, U. A. (2026). Design, Synthesis, and In Vitro Biological Assessment of Novel Benzimidazole and Hydrazone Derivatives Against Pancreatic Cancer and Melanoma Cells. Chemical Biology & Drug Design, 107(6). https://doi.org/10.1111/cbdd.70349

Vancouver

Bedir BEO, Sanci TO, Terzi E, Ercan E, Daoud NE, Çevik UA. Design, Synthesis, and In Vitro Biological Assessment of Novel Benzimidazole and Hydrazone Derivatives Against Pancreatic Cancer and Melanoma Cells. Chemical Biology & Drug Design. 2026;107(6). doi:10.1111/cbdd.70349

BibTeX
@article{Bedir2026,
  author = {Bedir, Beyza Ecem Oz and Sanci, Tuba Ozdemir and Terzi, Emine and Ercan, Elif and Daoud, Nour El-Huda and Çevik, Ulviye Acar},
  title = {Design, Synthesis, and In Vitro Biological Assessment of Novel Benzimidazole and Hydrazone Derivatives Against Pancreatic Cancer and Melanoma Cells},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {107},
  number = {6},
  doi = {10.1111/cbdd.70349}
}
Kostenlos starten →